Trials / Recruiting
RecruitingNCT06285357
The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Lo.Li.Pharma s.r.l · Industry
- Sex
- Female
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | EGCG + folic acid + B12 | EGCG + folic acid + B12 |
Timeline
- Start date
- 2024-02-19
- Primary completion
- 2026-03-01
- Completion
- 2026-08-01
- First posted
- 2024-02-29
- Last updated
- 2025-11-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06285357. Inclusion in this directory is not an endorsement.